Skip to main content

RT @uptoTate: In RA pts initiating their first b/tsDMARD, Abs 1420 did not observe differences in 6- and 12-month effect

Nov 13, 2022 6:39 pm
Social Author Name
Dr. Rachel Tate
Tweet Content
In RA pts initiating their first b/tsDMARD, Abs 1420 did not observe differences in 6- and 12-month effectiveness outcomes between ETN, ADA, and JAKi monotherapy. #ACR22 @RheumNow https://t.co/e8GA45Rrmd https://t.co/zooGxlTftO
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×